Table 1.
Biobank 1 | Biobank 2 | |||
---|---|---|---|---|
Clinical features | Control patients (N) | Invasive cancer (C) | Control patients (N) | Invasive cancer (C) |
Gender | ||||
Female | 12 (57%) | 9 (47%) | 24 (52%) | 16 (59%) |
Male | 9 (43%) | 10 (53%) | 22 (48%) | 11 (41%) |
Age (years, Median [range]) | 52 [19–64] | 69 [51–87] | 52 [23–81] | 66 [27–90] |
Weight (kg, Median [range]) | 70 [48–115] | 70 [50–100] | 71 [42–130] | 65 [40–89] |
Size (cm, Median [range]) | 164 [155–193] | 168 [157–182] | 168 [145–187] | 165 [153–185] |
Cancer stage | ||||
I | 2 (11%) | 4 (15%) | ||
II | 5 (26%) | 10 (37%) | ||
III | 5 (26%) | 7 (26%) | ||
IV | 7 (37%) | 6 (22%) | ||
Tumor location | ||||
Right colon | 11 (60%) | N/A | ||
Left colon | 8 (40%) | N/A |
Patients were selected randomly from two collections and included for the validation of FXIII by ELISA and AP-F13A1 by PRM assays. For cancer patients, they were classified according to cancer’s stage (I, II, III, IV) and the location of the primary tumor